Other

Tax Withholding for Share-Based Payments

Vertex Pharmaceuticals Tax Withholding for Share-Based Payments remained flat by 0.0% to $92.48M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 8.7%, from $101.25M to $92.48M. Over 2 years (FY 2023 to FY 2025), Tax Withholding for Share-Based Payments shows an upward trend with a 27.9% CAGR.

Analysis

StatementIncome Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2022
Last reportedQ3 2025

How to read this metric

An increase often correlates with higher employee stock compensation activity or rising share prices, representing a standard operational cash outflow.

Detailed definition

This represents the cash paid by the company to tax authorities on behalf of employees to satisfy tax obligations arisin...

Peer comparison

Often disclosed within the 'Financing' section of the cash flow statement as part of share-based payment adjustments.

Metric ID: is_anet_tax_withholding_share_based_payments

Historical Data

3 years
 FY'23FY'24FY'25
Value$226.10M$405.00M$369.90M
YoY Change+79.1%-8.7%
Range$226.10M$405.00M
CAGR+27.9%
Avg YoY Growth+35.2%
Median YoY Growth+35.2%

Tax Withholding for Share-Based Payments at Other Companies

Frequently Asked Questions

What is Vertex Pharmaceuticals's tax withholding for share-based payments?
Vertex Pharmaceuticals (VRTX) reported tax withholding for share-based payments of $92.48M in Q4 2025.
How has Vertex Pharmaceuticals's tax withholding for share-based payments changed year-over-year?
Vertex Pharmaceuticals's tax withholding for share-based payments decreased by 8.7% year-over-year, from $101.25M to $92.48M.
What is the long-term trend for Vertex Pharmaceuticals's tax withholding for share-based payments?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's tax withholding for share-based payments has grown at a 27.9% compound annual growth rate (CAGR), from $226.10M to $369.90M.
What does tax withholding for share-based payments mean?
Cash paid for taxes on behalf of employees for stock-based compensation.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.